Details

NameSymbolSector
CONCORD BIOTECH LIMITEDCONCORDBIOPharmaceuticals
Open
1633
High
1635.5
Low
1591.4
Close
1597.1
Volume
54957
Exchange
nse
Time
03-Oct-2025

Outlook

Score:  

2.5

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Concord Biotech is  
Opening Marubozu
Estimated Stoploss of Concord Biotech is ₹  
1635.5
Concord Biotech has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Concord Biotech has chances of  
Continuationℹ
 of the current trend. 

Trend

Concord Biotech is in  
Sideways trendℹ
. 
Price of Concord Biotech is  
Downℹ
 by  

4.16

%. 
Target
Buy @ 

1506.09

Sell @ 

1919.75

Current @ 

1597.1

Volume

The trade volumes of Concord Biotech have become  
Deficientℹ
The volume trend for Concord Biotech is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Concord Biotech is  

Down

 by  

57.32

% 

Valuation

The current market price of Concord Biotech is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 2034cr and total assets worth ₹ 2034cr, the balance sheet of Concord Biotech is:  
Balancedℹ
. 
Cashflow
Concord Biotech has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 14cr

. It is  
Downℹ
 by  

227.27

%. 

(*Mar 2025)

48.7% i.e. ₹ 244cr earned in operatingℹ
31.74% i.e. ₹ 159cr spent in investingℹ
19.56% i.e. ₹ 98cr spent in financingℹ
0% in otherℹ
Concord Biotech has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 11cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

51.16% i.e. ₹ 265cr earned in operatingℹ
29.73% i.e. ₹ 154cr spent in investingℹ
19.11% i.e. ₹ 99cr spent in financingℹ
0% in otherℹ
Income
The income of Concord Biotech is  

₹ 439cr

 and  

Profit

 is :  

₹ 141cr

(*Mar 2025)

Concord Biotech Profit is up by:  

90.54

% and Income is Up by:  

70.16

% 

(*Mar 2025)

The income of Concord Biotech is  

₹ 258cr

 and  

Profit

 is :  

₹ 74cr

(*Dec 2024)

Concord Biotech Profit is down by:  

24.49

% and Income is Down by:  

19.38

% 

(*Dec 2024)

The income of Concord Biotech is  

₹ 320cr

 and  

Profit

 is :  

₹ 98cr

(*Sep 2024)

Concord Biotech Profit is up by:  

68.97

% and Income is Up by:  

41.59

% 

(*Sep 2024)

By using this site you agree to the use of cookies to deliver a better site experience.